Medicare Pays For the AI Eye Scan — Nobody Pays For What Comes Next
Payment isn’t the only barrier, but it shapes all the others.
Healthcare Startups Highlight Direct-to-Consumer Diagnostics, Digital Twins, and Managing Pharmacy Costs at INVEST Digital Health Conference
MedCity News Editor-in-Chief Arundhati Parmar and Reporter Marissa Plescia interviewed a wide range of healthcare startups seeking to address painpoints in healthcare, from digital twin technology to support oncology drug development to alternative payment plans.
Doc at HLTH: I Can’t Imagine Seeing Patients Without AI
A part-time urgent care doctor who runs healthcare and life sciences projects at Anthropic as well as other AI experts discussed how AI can boost primary care.
Noom Introduces Wearable to Support Obesity Care Programs
Noom is launching a wearable in 2027 to support weight management and metabolic health through health tracking and personalized coaching.
J&J’s $2.2B Ollin Buyout Brings Late-Stage Eye Drug; Blackstone Deal Adds Trial Funding
Johnson & Johnson’s Ollin Biosciences acquisition comes with a Phase 3-ready bispecific antibody. The companies say this eye drug offers advantages over Vabysmo, a Roche drug approved for wet age-related macular degeneration and diabetic macular edema.